Table 1. Updated clinical classification of pulmonary hypertension (PH) (adapted from 6th WSPH document).
PAH |
Idiopathic PAH |
Heritable PAH |
Drug- and toxin-induced PAH (Table 2) |
PAH associated with |
Connective tissue disease |
HIV infection |
Portal hypertension |
Congenital heart disease |
Schistosomiasis |
PAH long-term responders to calcium channel blockers |
PAH with overt features of venous/capillaries (PVOD/PCH) involvement |
Persistent PH of the newborn syndrome |
PH due to left heart disease |
PH due to heart failure with preserved LVEF |
PH due to heart failure with reduced LVEF |
Valvular heart disease |
Congenital/acquired cardiovascular conditions leading to post-capillary PH |
PH due to lung diseases and/or hypoxia |
Obstructive lung disease |
Restrictive lung disease |
Other lung disease with mixed restrictive/obstructive pattern |
Hypoxia without lung disease |
Developmental lung disorders |
PH due to pulmonary artery obstructions |
Chronic thromboembolic PH |
Other pulmonary artery obstructions |
Sarcoma (high or intermediate grade) or angiosarcoma |
Other malignant tumours |
Renal carcinoma |
Uterine carcinoma |
Germ cell tumours of the testis |
Other tumours |
Non-malignant tumours: uterine leiomyoma |
Arteritis without connective tissue disease |
Congenital pulmonary artery stenoses |
Parasites |
PH with unclear and/or multifactorial mechanisms |
Haematological disorders: chronic haemolytic anaemia myeloproliferative disorders |
Systemic and metabolic disorders: pulmonary Langerhans cell histiocytosis, Gaucher disease, glycogen storage disease, neurofibromatosis, sarcoidosis |
Others: chronic renal failure with or without hemodialysis, fibrosing mediastinitis |
Complex congenital heart disease |
Segmental pulmonary hypertension: isolated pulmonary artery of ductal origin, absent pulmonary artery, pulmonary atresia with ventricular septal defect and major aorto-pulmonary collateral arteries, hemitruncus, other |
Single ventricle: unoperated, operated |
Scimitar syndrome |
PAH, pulmonary arterial hypertension; PVOD, pulmonary veno-occlusive disease; PCH, pulmonary capillary haemangiomatosis; LVEF, left ventricular ejection fraction.